EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 304 filers reported holding EDITAS MEDICINE INC in Q4 2021. The put-call ratio across all filers is 3.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109,496 | -10.1% | 14,038 | -5.0% | 0.17% | -4.9% |
| Q2 2023 | $121,746 | +13.6% | 14,775 | 0.0% | 0.18% | +4.6% |
| Q1 2023 | $107,125 | -18.3% | 14,775 | 0.0% | 0.17% | -2.8% |
| Q4 2022 | $131,054 | -27.6% | 14,775 | 0.0% | 0.18% | -2.2% |
| Q3 2022 | $181,000 | +1.7% | 14,775 | -2.0% | 0.18% | -1.6% |
| Q2 2022 | $178,000 | -38.0% | 15,076 | 0.0% | 0.19% | -29.0% |
| Q1 2022 | $287,000 | -28.6% | 15,076 | -0.3% | 0.26% | -28.4% |
| Q4 2021 | $402,000 | -35.3% | 15,126 | 0.0% | 0.37% | -39.9% |
| Q3 2021 | $621,000 | -30.5% | 15,126 | -4.2% | 0.61% | -29.1% |
| Q2 2021 | $894,000 | +20.5% | 15,784 | -10.7% | 0.86% | +12.7% |
| Q1 2021 | $742,000 | -39.6% | 17,672 | +0.9% | 0.76% | -42.3% |
| Q4 2020 | $1,228,000 | – | 17,522 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |